Ganglion sentinelle et cancer opérable du sein : utilisation du bleu patent. Étude pilote
- 30 April 2000
- journal article
- clinical trial
- Published by Elsevier BV in Annales de Chirurgie
- Vol. 125 (3), 253-258
- https://doi.org/10.1016/s0001-4001(00)00139-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Le ganglion sentinelle dans les cancers opérables du seinChirurgie, 1999
- Refining the optimal technical approach for sentinel node localization in breast cancer patients.Annals of Surgical Oncology, 1999
- The impact of local regional therapy on breast cancer survival.Annals of Surgical Oncology, 1999
- Intradermal Radiocolloid and Intraparenchymal Blue Dye Injection Optimize Sentinel Node Identification in Breast Cancer PatientsAnnals of Surgical Oncology, 1999
- Twelve years of experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographicsThe Breast, 1997
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysisCancer, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Impact of axillary lymph node dissection on the therapy of breast cancer patients.Journal of Clinical Oncology, 1993
- Axillary dissection of level I and II lymph nodes is important in breast cancer classificationEuropean Journal of Cancer, 1992